NM_018076.5:c.2675C>A
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_018076.5(ODAD2):c.2675C>A(p.Ser892*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_018076.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 23Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_018076.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ODAD2 | NM_018076.5 | MANE Select | c.2675C>A | p.Ser892* | stop_gained | Exon 18 of 20 | NP_060546.2 | ||
| ODAD2 | NM_001290020.2 | c.2675C>A | p.Ser892* | stop_gained | Exon 18 of 20 | NP_001276949.1 | |||
| ODAD2 | NM_001312689.2 | c.1751C>A | p.Ser584* | stop_gained | Exon 13 of 15 | NP_001299618.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ODAD2 | ENST00000305242.10 | TSL:1 MANE Select | c.2675C>A | p.Ser892* | stop_gained | Exon 18 of 20 | ENSP00000306410.5 | ||
| ODAD2 | ENST00000673439.1 | c.2675C>A | p.Ser892* | stop_gained | Exon 18 of 20 | ENSP00000500782.1 | |||
| ODAD2 | ENST00000672841.1 | c.1751C>A | p.Ser584* | stop_gained | Exon 13 of 15 | ENSP00000499983.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia 23 Pathogenic:3
The homozygous p.Ser892Ter variant in ARMC4 was identified by our study in two siblings with congenital fibrosis of the extraocular muscles, global developmental delay, situs inversus, and ciliary dyskinesia, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Engle lab (https://kirbyneuro.org/EngleLab/). The p.Ser892Ter variant in ARMC4 has been previously reported in 2 unrelated individuals with primary ciliary dyskinesia 23 (PMID: 24203976, PMID: 23849778) and segregated with disease in 2 affected relatives from one family (PMID: 24203976). These two affected unrelated individuals were homozygotes, which increases the likelihood that the p.Ser892Ter variant is pathogenic. This variant has also been reported in ClinVar (Variation ID: 66047) and has been interpreted as pathogenic by the Lupski Lab of the Baylor College of Medicine and by OMIM. This variant was absent from large population studies. This nonsense variant leads to a premature termination codon at position 892, which is predicted to lead to a truncated or absent protein. Loss of function of the ARMC4 gene is an established disease mechanism in autosomal recessive primary ciliary dyskinesia 23. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive primary ciliary dyskinesia 23. ACMG/AMP Criteria applied: PVS1, PM2_Supporting, PM3 (Richards 2015).
This homozygous mutation was predicted to be loss-of-function.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at